巯基嘌呤甲基转移酶在嘌呤类药物代谢中的作用及其多态性的研究进展
摘要
对巯基嘌呤甲基转移酶在巯嘌呤类药物体内代谢过程中的作用、其活性水平与药物活性物质在体内的浓度与药效、药物的毒副作用的关系、酶活性多态性种族差异及基因遗传多态性关系进行综述。为指导临床合理用药,避免药物不良反应及个体化用药提供参考。
出处
《医药导报》
CAS
2009年第4期493-495,共3页
Herald of Medicine
参考文献30
-
1KRYNETSKI E Y, TAI H L, YATES C R, et al. Genetic polymorphism of thiopurine S-methyhransferase : clinical importance and molecular mechanisms [J]. Pharmacogertetics, 1996, 6(4) : 279 - 290. 被引量:1
-
2COLOMBEL J F, FERRARI N, DEBUYSERE H, et al. Genotypic analysis of thiopurine S-methyhransferase in patients with Crohn's disease and severe myelosuppression during azathioprine therapy [J]. Gastroenterology, 2000, 118(6) : 1025 - 1030. 被引量:1
-
3GUNNARSDOTYIR S , ELFARRA A A. Distinct tissue distribution of metabolites of the novel glutathione activated thiopurine prodrugs cis-6-( 2-aeetylvinylthio ) purine and trans-6-( 2-acetylvinylthio ) guanine and 6-thioguanine in the mouse [ J ]. Drug Metab Disposition, 2003, 31(6): 718-726. 被引量:1
-
4BAKER D E, PHARM D, FASCP, FASHP. Pharmacogenomics of azathioprine and 6-mercaptopurine in gastroenterologic therapy [ J ]. Rev Gastroenterol Disord, 2003, 3(3): 150- 157. 被引量:1
-
5AHMED M, MD SANDHYA S, et al. Relationship between 6-mercaptopurine dose and 6-thioguanine nucleotide levels in patients with inflammatory bowel disease [ J ]. Inflamm Bowel Dis, 2007, 13 (2) : 380 - 385. 被引量:1
-
6詹钟平,杨岫岩,黄民,王一西,连帆,梁柳琴,叶玉津,许韩师.硫唑嘌呤致血液系统危象的临床特征与酶学基础[J].中华风湿病学杂志,2005,9(3):145-148. 被引量:16
-
7魏红,李成荣,李智毅,刘芳,黄民,王国兵,吴珏珩,张建萍.硫嘌呤甲基转移酶遗传多态性检测在6-MP个体化治疗中的意义[J].中国医院药学杂志,2007,27(1):5-7. 被引量:7
-
8LENNARD L, LILLEYMAN J S, VAN LOON J, et al. Genetic variation in response to 6-mercaptopurine for childhood acute lymphoblastic leukaemia [ J ]. Lancet, 1990, 336 ( 8709 ) : 225- 229. 被引量:1
-
9LENNARD L, GIBSON B E, NICOLE T, et al. Congenital thiopurine methyltransferase deficiency and 6-mercaptopurine toxicity during treatment for acute lymphoblastic leukaemia [ J ]. Arch Dis Childhood, 1993, 69 (5) :577 - 579. 被引量:1
-
10詹钟平,杨岫岩,梁柳琴,王一西,黄民,连帆.风湿病患者硫唑嘌呤代谢酶活性分布及其临床意义[J].中华内科杂志,2006,45(7):537-539. 被引量:5
二级参考文献59
-
1詹钟平,杨岫岩,黄民,王一西,连帆,梁柳琴,叶玉津,许韩师.硫唑嘌呤致血液系统危象的临床特征与酶学基础[J].中华风湿病学杂志,2005,9(3):145-148. 被引量:16
-
2张建萍 黄民 关永源 等.广东瑶族和汉族儿童TPMT遗传多态性研究[J].中国临床药理学杂志,2002,18:418-421. 被引量:1
-
3Zhang JP, Huang M, Guan YY, et al. Molecular mechanisms of genetic polymorphim of thiopurine S-methyltransferase. Chin J Clin Pharmacol, 2002, 18 , 453-457. 被引量:1
-
4Yates CR, Krynetski EY, Loennechen T, et al. Molecular diagnosis of thiopurine S-methyltransferase deficiency: genetic basts for azathiopurine and mercaptopurine intolerance. Ann Intern Med, 1997, 126: 608-614. 被引量:1
-
5Tai HL, Fessing MY, Bonten EJ, et al. Enhanced proteasomal degradation of mutant human thiopurine S-methyltransferase(TPMT) in mammalian cells: mechanism for TPMT protein deficiency inherited by TPMT * 2, TPMT * 3A, TPMT * 3B or TPMT * 3C. Pharmacogenetics, 1999, 9: 641-650. 被引量:1
-
6Collie-Duguid ES, Pritchard SC, Powrie RH, et al. The frequency and distribution of thiopurine methyltransferase alleles in Caucasian and Asian populations. Pharmacogenetics, 1999,9: 37-42. 被引量:1
-
7Weinshilboum R. Thiopurine pharmacogenetics: clinical and molecular studies of thiopurine methyltransferase. Drug Metab Dispos, 2001, 29: 601-605. 被引量:1
-
8Spire-Vayron de la Moureyre C, Debuysere H, Sabbagh N, et al.Detection of known and new mutations in the thiopurine S-methyltransferase gene by single-strand conformation polymorphism analysis. Hum Murat, 1998, 12, 177-185. 被引量:1
-
9Colombel JF, Ferrari N, Debuysere H, et al. Genotypic analysis of thiopurine S-methyltransferase in patients with Crohn's disease and severe myelosuppression during azathiopurine therapy.Gastroenterology, 2000, 118: 1025-1030. 被引量:1
-
10Otterness D, Szumlanski C, Lennard L, et al. Human thiopurine methyltransferase pharmacogenetics : gene sequence polymorphisms. Clin Pharmacol Ther, 1997, 62: 60-73. 被引量:1
共引文献38
-
1胡坚,李崇巍,马继军,张先喜,韩红玲.第1例 严重脱发和骨髓抑制:是系统性红斑狼疮加重吗?[J].中国循证儿科杂志,2006,1(1):62-65.
-
2詹钟平,杨岫岩,梁柳琴,王一西,黄民,连帆.风湿病患者硫唑嘌呤代谢酶活性分布及其临床意义[J].中华内科杂志,2006,45(7):537-539. 被引量:5
-
3于连英,傅淑霞.硫唑嘌呤致严重脱发1例[J].临床荟萃,2007,22(3):228-228. 被引量:5
-
4詹钟平,梁柳琴,杨岫岩,王一西,黄民,李昊.风湿病人群硫唑嘌呤代谢酶基因型与药物耐受性的关系[J].中华医学杂志,2007,87(25):1734-1737. 被引量:4
-
5侯志铎,肖征宇,曾庆馀.小剂量硫唑嘌呤在风湿病治疗中的不良反应[J].中华风湿病学杂志,2008,12(2):116-118. 被引量:3
-
6陈战瑞,赵铖.硫唑嘌呤致急性造血功能停滞SLE患者长期维持缓解1例[J].现代中西医结合杂志,2008,17(21):3367-3367.
-
7王振刚.改变病情的抗风湿药物(一)[J].临床药物治疗杂志,2008,6(4):39-45. 被引量:1
-
8徐建华.抗风湿药物基因组学研究应受到关注[J].中华风湿病学杂志,2008,12(9):585-587. 被引量:1
-
9纪立伟,刘岳.警惕硫唑嘌呤引起的急性骨髓抑制[J].中国临床医生杂志,2009,37(9):64-65. 被引量:2
-
10郑花鸯,严安,熊慧.肿瘤的个体化医疗[J].肿瘤,2009,29(9):822-827. 被引量:7
-
1梁爱斌.嘌呤类药物作用及巯基嘌呤甲基转移酶遗传多态性的研究进展[J].中华血液学杂志,1998,19(2):110-112.
-
2毛晨梅,吕文莉,万舒欣,薛丰,平其能.HPLC法测定人血红细胞巯基嘌呤甲基转移酶的活性[J].中国药科大学学报,2008,39(1):42-45. 被引量:2
-
3张铭穹,黄纯,林晓芳,杜青云.嘌呤类抗病毒药物的药理及临床应用[J].华西药学杂志,1998,13(4):247-249.
-
4潘启超.抗肿瘤药物的进展[J].四川肿瘤防治,1998,11(3):46-51. 被引量:1
-
5李阅东,姚成娥,沈如杰,唐建飞,何海珍,赵福斌.选择性黄嘌呤氧化酶抑制剂非布司他的临床研究进展[J].中国药房,2013,24(26):2472-2475. 被引量:12
-
6谢偲,岳丽杰.基因多态性对巯嘌呤类药物作用影响的研究进展[J].中国临床药理学与治疗学,2014,19(7):818-824. 被引量:2
-
7李志玲,王鹤尧,孙华君.巯嘌呤类药物用于儿童急性淋巴细胞性白血病患者个体化治疗的研究进展[J].上海医药,2015,36(19):12-15. 被引量:6
-
8谢偲,岳丽杰.巯嘌呤甲基转移酶基因多态性与巯嘌呤类药物治疗关系的研究进展[J].中国临床药理学杂志,2013,29(11):865-868. 被引量:2
-
9刘维萍,张彦芬,李涛,郭永力,管仁苹,吴学敏,魏鹍.硫唑嘌呤致无TPMT基因常见致病位点突变患者严重脱发和骨髓抑制一例[J].中华肾病研究电子杂志,2014,3(5):45-46. 被引量:3
-
10魏红,李智毅,赵霞,陈淑丽,王国兵,石红松,黄民,张建萍,吴珏珩.TPMT与ITPA遗传多态性与6-巯基嘌呤不良反应的关系[J].中国医院药学杂志,2010,30(24):2062-2067. 被引量:4